beta-hydroxyisovalerylshikonin has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narahara, H; Nasu, K; Nishida, M; Takai, N; Ueda, T | 1 |
1 other study(ies) available for beta-hydroxyisovalerylshikonin and Ovarian Neoplasms
| Article | Year |
|---|---|
Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
Topics: Apoptosis; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Endometrial Neoplasms; Female; Humans; Intracellular Signaling Peptides and Proteins; Membrane Potential, Mitochondrial; Naphthoquinones; Ovarian Neoplasms; Up-Regulation | 2008 |